John Kiely, Director at Amneal Pharmaceuticals, Inc. (AMRX), sold 60,000 shares at $17.64 ($882K) on 2026-08-13, disclosed to the SEC on 2026-08-14.
Open-market sale of $882k AMRX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 10,000 | $0 | 0.0% |
| 2 | $17.64 | 50,000 | $882K | 100.0% |
| Total | $14.70 avg | 60,000 | $882K | 100% |
| Filing → |
| AMRX | SELL | 2024-11-26 | $286K | — | Filing → |
| ZVO | BUY | 2020-09-10 | $43K | — | Filing → |
| AMRX | BUY | 2020-05-19 | $44K | — | Filing → |